CP - Straight from the last Investor Update - pg 3
"First is the continued development of CVacTM’s safety profile. With each new patient, we have additional confidence that CVacTM is a well tolerated and non-toxic treatment. The last patient will receive the last dose of CVacTM in October. An update on safety data can then be expected before the end of 2012"
Lots more exciting stuff in the pipeline also -
http://www.primabiomed.com.au/investor/investor_update_pdf/Prima_Newsletter_JUNE_2012_RZ02_screen.pdf
Cheers
CP - Straight from the last Investor Update - pg 3 "First is the...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.8¢ | $80.82K | 242.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29609 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 334991 | 14 |
View Market Depth
| Last trade - 10.27am 15/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |